[Evaluation of Rivanol in the aspect of post-therapeutic complications].
D000166:Acridines / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000175:diagnosis*; D004975:Ethacridine / Q000009:adverse effects* / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D010328:Patch Tests
D000166:Acridines; D004975:Ethacridine
Ocena rywanolu w aspekcie powikłań poleczeniowych.